European Heart Journal
European Heart Journal is a peer-reviewed medical journal that focuses on cardiology. It is published by the Oxford University Press on behalf of the European Society of Cardiology. The journal publishes original research articles, review articles, and editorial content focused on cardiology and cardiovascular disease.
History[edit]
The European Heart Journal was established in 1980 by the European Society of Cardiology. The journal has grown in scope and impact over the years, becoming one of the most influential journals in the field of cardiology.
Content[edit]
The journal publishes a wide range of content, including original research articles, review articles, case reports, and editorials. The topics covered by the journal include, but are not limited to, coronary artery disease, heart failure, arrhythmia, valvular heart disease, hypertension, and vascular disease.
Impact[edit]
The European Heart Journal is considered one of the leading journals in the field of cardiology. It has a high impact factor, indicating that its articles are frequently cited in other scholarly works. The journal's impact factor and reputation make it a key resource for researchers and clinicians in the field of cardiology.
Editorial Process[edit]
The editorial process at the European Heart Journal is rigorous and involves peer-review by experts in the field. The journal's editorial board is composed of renowned cardiologists from around the world, ensuring a high standard of review.
Access[edit]
The European Heart Journal is available in both print and online formats. The online version is accessible through the journal's website and includes access to all articles published in the journal.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
